We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.36B
AUM Growth
-$1.68B
Cap. Flow
-$1.45B
Cap. Flow %
-43.28%
Top 10 Hldgs %
28.65%
Holding
6,080
New
399
Increased
1,937
Reduced
2,718
Closed
947

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$126M
2
NVDA icon
NVIDIA
NVDA
+$101M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$97.8M
4
MSFT icon
Microsoft
MSFT
+$89.5M
5
AMZN icon
Amazon
AMZN
+$44.3M

Sector Composition

Rank Sector Weight
1 Technology 19.97%
2 Financials 9.87%
3 Consumer Discretionary 8.34%
4 Healthcare 7.98%
5 Communication Services 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDY icon
3826
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.4B
$9.07K ﹤0.01%
17
-9,505
-100% -$5.4M
SHLS icon
3827
Shoals Technologies Group
SHLS
$1.42B
$9.07K ﹤0.01%
2,731
-12,794
-82% -$53.2K
COFS icon
3828
Choiceone Financial
COFS
$514M
$9.06K ﹤0.01%
315
-564
-64% -$18.1K
INSE icon
3829
Inspired Entertainment
INSE
$164M
$9.06K ﹤0.01%
1,061
-1,610
-60% -$15.5K
CRD.A icon
3830
Crawford & Co Class A
CRD.A
$632M
$9.04K ﹤0.01%
792
-1,215
-61% -$14.2K
BIOA
3831
BioAge Labs
BIOA
$487M
$9.04K ﹤0.01%
2,404
-1,274
-35% -$5.89K
OBDC icon
3832
Blue Owl Capital
OBDC
$5.78B
$9.03K ﹤0.01%
616
-12,422
-95% -$187K
ZROZ icon
3833
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.29B
$9.03K ﹤0.01%
+126
New +$8.8K
MRSN
3834
DELISTED
Mersana Therapeutics
MRSN
$9.01K ﹤0.01%
1,047
+689
+192% +$10.6K
AGEN
3835
Agenus
AGEN
$329M
$9K ﹤0.01%
5,978
+514
+9% +$1.48K
TNGX icon
3836
Tango Therapeutics
TNGX
$4.32B
$8.99K ﹤0.01%
6,566
+757
+13% +$1.86K
NGL icon
3837
NGL Energy Partners
NGL
$2.24B
$8.99K ﹤0.01%
1,981
+1,667
+531% +$8.28K
SLRN
3838
DELISTED
ACELYRIN
SLRN
$8.98K ﹤0.01%
3,637
-3,260
-47% -$7.75K
BHB icon
3839
Bar Harbor Bankshares
BHB
$681M
$8.94K ﹤0.01%
303
-4,804
-94% -$150K
PTN
3840
Palatin Technologies
PTN
$16.7M
$8.94K ﹤0.01%
307
+197
+179% +$9.17K
STRO icon
3841
Sutro Biopharma
STRO
$340M
$8.92K ﹤0.01%
1,371
+600
+78% +$9.45K
ARAY icon
3842
Accuray
ARAY
$33.2M
$8.92K ﹤0.01%
4,995
-710
-12% -$1.49K
FBYD icon
3843
Falcon's Beyond
FBYD
$1.2B
$8.9K ﹤0.01%
1,021
+182
+22% +$1.26K
HOWL icon
3844
Werewolf Therapeutics
HOWL
$19.7M
$8.89K ﹤0.01%
9,142
+3,286
+56% +$4.3K
CABA icon
3845
Cabaletta Bio
CABA
$466M
$8.88K ﹤0.01%
6,415
-6,187
-49% -$13.2K
CYRX icon
3846
CryoPort
CYRX
$772M
$8.86K ﹤0.01%
1,458
+184
+14% +$1.27K
WOW
3847
DELISTED
WideOpenWest
WOW
$8.86K ﹤0.01%
1,789
-2,329
-57% -$10.7K
FSP
3848
Franklin Street Properties
FSP
$50.8M
$8.82K ﹤0.01%
4,956
-14,698
-75% -$27.1K
DBC icon
3849
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
$8.82K ﹤0.01%
+392
New +$8.69K
GORO icon
3850
Goldgroup Mining
GORO
$207M
$8.81K ﹤0.01%
17,284
-8,598
-33% -$3.57K

Similar funds

Tower Research Capital (TRC)'s Q1 2025 Portfolio in Review

As of Q1 2025, Tower Research Capital (TRC) held 6,080 positions worth $3.36B, down 33% from $5.04B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.45B in Q1 2025, closing 947 positions and reducing 2,718 holdings. Its most notable exit was Listed Funds Trust Roundhill Magnificent Seven ETF, an estimated $8.86M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $18.3M.

  • Tower Research Capital (TRC)'s largest Q1 2025 buy was Vanguard S&P 500 ETF: 35,404 shares worth $18.3M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2025, an estimated $274M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2025 reduction was Apple, cutting an estimated $126M.
  • Tower Research Capital (TRC) fully exited Listed Funds Trust Roundhill Magnificent Seven ETF in Q1 2025, selling an estimated $8.86M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3.36B portfolio in Q1 2025.
  • Tower Research Capital (TRC) opened 399 new positions and closed 947 in Q1 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 33% quarter-over-quarter to $3.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.